猪卵母细胞玻璃化冷冻后细胞骨架的变化

为研究玻璃化冷冻后猪卵母细胞纺锤体、染色体和微丝的变化,从屠宰猪卵巢表面直径2—5mm卵泡中采集未成熟(GV)期卵母细胞,由GV期卵母细胞经成熟培养获得体外成熟(MⅡ)期卵母细胞。GV期和MⅡ期卵母细胞各分为3组对照组、冷冻保护剂处理组和玻璃化冷冻组。MⅡ期卵母细胞经分组处理后直接用于激光扫描共聚焦显微镜(LSCM)观察样本;而GV期卵母细胞处理后先经44h成熟培养,再用作LSCM观察样本。供试卵母细胞经固定、免疫荧光染色后,于LSCM下观察。结果表明,冷冻保护剂处理组GV期卵母细胞经成熟培养后,其纺锤体结构、染色体排列与微丝分布正常率分别为42.9%、89.6%和28.6%;玻璃化冷冻组此3项指标的正常率分别为10.1%、36.4%和16.9%,两组间差异显著(P<0.05);除冷冻保护剂处理组染色体正常率与对照组无较大差异外,两试验组的其他指标均明显低于对照组(分别为79.5%、93.1%和72.3%,P<0.05)。MⅡ期卵母细胞冷冻保护剂处理组的纺锤体结构、染色体排列与微丝分布正常率分别为34.4%、61.3%和47.9%,而冷冻组分别为12.9%、56.7%和37.2%,两组均显著低于对照组(分别为78.3%、90.1%和72.8%,P<0.05)。结果表明,猪GV期和MⅡ期卵母细胞经冷冻保护剂处理或玻璃化冷冻保存后,均造成了纺锤体、染色体和微丝不可逆的损伤,这可能是影响卵母细胞成熟、受精与发育的重要原因。     

牛卵母细胞玻璃化冷冻保存影响因素的研究

采用毛细玻璃管法对牛卵母细胞进行玻璃化冷冻保存,解冻后再进行体外受精（IVF）和早期胚胎的体外培养（IVC）。在此技术的基础上,分别对冷冻前平衡时间、解冻处理、卵丘细胞层数以及卵母细胞所处的减数分裂阶段等影响卵母细胞冷冻保存的因素进行研究,以期筛选出适合牛卵母细胞冷冻保存的方法。结果发现,处于MⅡ期卵母细胞在10％二甲基亚砜（DMSO）＋10％乙二醇（EG）液（VSl）中平衡1～3min,然后进行玻璃化冷冻保存。解冻时将卵母细胞先移入VS1液中处理15s,然后移入蔗糖稀释液中。另外发现,冷冻保存时部分卵丘细胞对卵母细胞有保护作用。而减数分裂阶段不影响解冻后卵母细胞形态正常率,但对胚胎发育率有严重影响。     

3种玻璃化冷冻液对水牛MⅡ期卵母细胞冷冻-解冻后体外发育的影响

本试验主要探索了3种玻璃化冷冻液对水牛MⅡ期卵母细胞冷冻一解冻后体外发育的影响.水牛MⅡ期卵母细胞经3组玻璃化冷冻液(Ⅰ:20%乙二醇(EG)+20%二甲基亚砜(DMSO);Ⅱ:20%EG+20%丙二醇(PROH);Ⅲ:20%EG+20%PROH+10%DMSO)毒性试验后,Ⅰ、Ⅱ和Ⅲ组体外受精的分裂率、8-细胞率和囊胚率之间差异不显著(P>0.05),分裂率均显著低于对照组(P<0.05),但Ⅱ组8-细胞以后的发育潜力跟对照组无显著差异(P>0.05).进一步比较了3组玻璃化冷冻液对卵母细胞的玻璃化冷冻效果.卵子解冻后进行体外受精后,Ⅰ、Ⅱ和Ⅲ组的发育潜力均显著低于对照组(P<0.05),各组的8-细胞率和囊胚率之间无显著差异(P>0.05),但Ⅱ组卵裂率明显高于Ⅰ组(24.8±4.6%vs12.7±1.5%,P<0.05).结果表明,3种冷冻玻璃化保护液均可用于冷冻水牛MⅡ期卵母细胞,其中Ⅱ组处理的卵母细胞体外受精效果相对较好.     

有无卵丘细胞对猪GV期卵母细胞玻璃化冷冻的影响

本研究探讨卵丘细胞对猪GV期卵母细胞玻璃化冷冻效果的影响。根据卵丘细胞层数将体外收集的猪卵母细胞分成对照组、A组(3层以上卵丘细胞)、B组(2~3层以上卵丘细胞)、C组(裸卵),研究卵母细胞玻璃化冷冻后的存活率、成熟率和孤雌激活后发育潜能的变化。结果表明:玻璃化冷冻后B组和A组的卵母细胞存活率显著高于C组(p0.01);冻融后的卵母细胞在成熟率方面的表现为:A、B、C三组的成熟率分别为22.17%、27.2%和18.15%,其中B组的成熟率显著高于C组(p0.05),但均明显低于对照组(p0.01)。通过进一步的孤雌激活发现,冻融后卵母细胞的卵裂率、4~8细胞卵裂率和囊胚率在3组中均无显著性差异(p0.05),均显著低于对照组(p0.01),但B组与其中两组相比具有上升趋势。综上所述,玻璃化冷冻时保留部分卵丘细胞可以降低冷冻对猪GV期卵母细胞造成的损伤。     

猪卵母细胞玻璃化冷冻后细胞骨架的变化

为研究玻璃化冷冻后猪卵母细胞纺锤体、染色体和微丝的变化，从屠宰猪卵巢表面直径2—5 mm卵泡中采集未成熟(GV)期卵母细胞，由GV期卵母细胞经成熟培养获得体外成熟(MⅡ)期卵母细胞。GV期和MⅡ期卵母细胞各分为3组：对照组、冷冻保护剂处理组和玻璃化冷冻组。MⅡ期卵母细胞经分组处理后直接用于激光扫描共聚焦显微镜(LSCM)观察样本；而GV期卵母细胞处理后先经44 h成熟培养，再用作LSCM观察样本。供试卵母细胞经固定、免疫荧光染色后，于LSCM下观察。结果表明，冷冻保护剂处理组GV期卵母细胞经成熟培养后，其纺锤体结构、染色体排列与微丝分布正常率分别为42.9%、89.6%和28.6%；玻璃化冷冻组此3项指标的正常率分别为10.1%、36.4%和16.9%，两组间差异显著(P<0.05)；除冷冻保护剂处理组染色体正常率与对照组无较大差异外，两试验组的其他指标均明显低于对照组(分别为79.5%、93.1%和72.3%，P<0.05)。MⅡ期卵母细胞冷冻保护剂处理组的纺锤体结构、染色体排列与微丝分布正常率分别为34.4%、61.3%和47.9%，而冷冻组分别为12.9%、56.7%和37.2%，两组均显著低于对照组(分别为78.3%、90.1%和72.8%，P<0.05)。结果表明，猪GV期和MⅡ期卵母细胞经冷冻保护剂处理或玻璃化冷冻保存后，均造成了纺锤体、染色体和微丝不可逆的损伤，这可能是影响卵母细胞成熟、受精与发育的重要原因。     

玻璃化冷冻对猪体外成熟卵母细胞染色体与纺锤体的影响

以冷冻环为载体,探讨玻璃化冷冻对猪体外成熟卵母细胞染色体与纺锤体影响。单用40%乙二醇(ethyleneglycol,EG)或20%EG与20%二甲基亚砜(dimethylsulphoxide,DMSO)联合作冷冻保护剂,用直投液氮或使用玻璃化冷冻仪法制冷冷冻猪体外成熟卵母细胞;解冻2h后固定并免疫荧光法染色纺锤体及染色体;挑选各试验组形态正常卵母细胞进行体外受精实验。结果表明,与单用EG以及EG和DMSO联合直投液氮方案比较,EG和DMSO联合应用并采用玻璃化冷冻仪制冷方案卵母细胞染色体正常率为30.1%,纺锤体正常率为37.2%,可明显降低卵母细胞染色体及纺锤体结构损伤(P<0.05),并明显提高卵母细胞的激活效果(P<0.05)。采用联合冷冻保护剂及玻璃化冷冻仪高速冷冻可较好维持猪卵母细胞染色体与纺锤体形态,但玻璃化冷冻明显影响猪卵母细胞体外受精后的发育能力。     

银鲫卵母细胞体外诱导成熟技术的建立

研究以银鲫为材料, 根据银鲫(Carassius auratus gibelio)卵母细胞生发泡(Germinal vesicle, GV)边移程度及剥离GV中减数分裂前期染色体的凝集状态, 将银鲫Ⅳ时相的卵母细胞分为GV0、GV1、GV2和GV3四个时期; 并进一步比较了分别处于这4个时期银鲫卵母细胞体外诱导培养的成熟率、卵裂率和孵化率。结果表明, GV1期之后的卵母细胞均可有效进行体外诱导成熟, 可正常受精发育, 由于GV1期卵母细胞有较长时间用于显微操作, 因此GV1期卵母细胞被选为进行体外诱导的最早时期的卵母细胞。以GV1期卵母细胞为研究材料, 摸索了银鲫卵母细胞体外诱导成熟的适宜条件: 取GV1期的Ⅳ时相卵母细胞, 放置于pH 8.5、加有1 μg/mL孕酮激素(17α, 20β-dihydroxy-4-pregnen-3-one, DHP)的格氏平衡盐溶液(Gey’s balanced salt solution, GBSS)中, 在23℃培养箱中体外诱导12h后, 将滤泡膜剥离后再进行人工体外授精, 其所获胚胎的孵化率可达55.5%。此外, 将体外转录合成的带GFP标签的h2af1o mRNA注射到GV1期卵母细胞, 发现经显微操作和体外诱导后不仅可以通过GFP绿色荧光信号活体观察GVBD、受精、卵裂和早期胚胎发育的全过程, 而且诱导成熟的卵子仍可正常受精和胚胎发育。研究建立的银鲫卵母细胞体外诱导成熟技术为银鲫和其他鱼类卵母细胞发育过程研究及其相关基因和细胞显微操作提供了技术平台。     

食蟹猴和恒河猴卵母细胞及早期胚胎玻璃化冻存

为了节省经费和使转基因模型动物品种资源得到妥善保存,该研究利用自制的梯度浓度冷冻液和解冻液结合玻璃化方式分别冷冻和解冻了非人灵长类动物的183个卵母细胞（GV期、MI期和MII期）、114个卵裂期胚胎（2-细胞期、4-细胞期和8-细胞期）及25个桑椹期胚胎。其中食蟹猴卵母细胞67个,卵裂期胚胎45个,桑椹期胚胎11个;恒河猴卵母细胞116个,卵裂期胚胎69个,桑椹期胚胎14个。复苏后存活率分别为56/67（83.58%）、36/45（80.00%）、9/11（81.82%）、102/116（87.93%）、55/69（79.71%）和11/14（78.57%）。结果表明,快速玻璃化冷冻法简便且胚胎存活率高,是一种较好的冷冻食蟹猴和恒河猴卵母细胞及胚胎的方法。     

不同年龄昆明白小鼠卵母细胞的生发泡互换

为探讨卵母细胞减数分裂异常及其与年龄相关变化之间的关系,对不同年龄段昆明白小鼠卵母细胞进行了生发泡(GV)移植研究。应用显微操作和电融合技术,将6~8周龄小鼠GV期卵母细胞分别与6月龄9、月龄和12月龄小鼠GV期卵母细胞进行GV互换,所形成的6种GV-胞质体复合体的融合率(89.7%~95.6%)和6种重组卵母细胞的成熟率(83.5%~88.2%)并不因小鼠年龄的改变而有所变化。成熟的6种重组卵母细胞经体外受精后,形成原核期胚和2-细胞期胚的比率(分别为80.0%~87.3%和42.7%~50.9%)并不因不同年龄小鼠卵母细胞GV互换所带来的细胞质或细胞核的改变而受到影响。     

小鼠卵母细胞体外成熟、体外受精的效果观察

目的　研究不同培养条件对小鼠卵母细胞体外成熟及体外受精率的影响。方法　小鼠卵母细胞分别在含有FSH、BSA和胰岛素的培养液中体外成熟,在Whitten 氏液中体外受精,比较体外成熟率、体外受精率。结果　1- 裸卵(DO) 的体外成熟率、体外受精率(81-4% ,31-0 % ) 均高于卵丘卵母细胞复合体(COC)(48-6 % ,27-1% ) 。2- 在培养液中添加FSH、胰岛素和BSA,卵母细胞的体外成熟率为77-9 % ,82-3% 、60-7% ;体外受精率为77-2 % 、72-6 % 、26-7% ;2 - 细胞率为49-2 % 、34-2 % 、10-0% 。胰岛素组的卵母细胞IVM 率最高,但IVF率、2 - 细胞率低于FSH 组。3- 添加BSA的两组的体外受精率只有26-7 % 、25-8 % ,显著低于其他组,其体外成熟率也较添加FSH 和胰岛素的组成。4- 排出第一极体(PbI) 的卵母细胞的体外受精率和2 - 细胞率(85-9 % ,22-4% ) 均高于GV期卵母细胞(71-1 % ,12-9 % ) 。结论　1- 卵丘卵母细胞(COC) 较裸卵(DO) 的体外成熟率、体外受精率都低,差异显著(P成熟< 0-01;P受精< 0-05) 。2-FSH 和胰岛素均能提高小鼠卵母细胞的体外成熟率、体外受精率。3-BSA可以降低小鼠卵母细胞体外受精率,差异极显著。4-GV 期卵母细胞的体外受精率显著低于体外培养的排出第一极体的卵母细胞(P2 - cell < 0-05,P受精<0-05)     

Comparison of cytoskeletal integrity,fertilization and developmental competence of oocytes vitrified before or after in vitro maturation in a porcine model

Aim of the study was to investigate the effect of vitrification on viability, cytoskeletal integrity and in vitro developmental competence after in vitro fertilization (IVF) of oocytes vitrified before or after in vitro maturation (IVM) using a pig model. Oocytes from abattoir-derived porcine ovaries were vitrified at either the germinal vesicle (GV) or metaphase II (MII) stage by modified solid surface vitrification (SSV). Oocyte viability was evaluated by stereomicroscopic observation whereas their nuclear stage and morphology of microtubules and F-actin were observed by confocal microscopy after immunostaining. Fertilization was assessed by orcein staining. The survival rate after vitrification was higher for MII-stage than for GV-stage oocytes. However, the ability of surviving oocytes to reach the MII stage after vitrification at the GV stage (GV-vitrified oocytes) was similar to that of control oocytes. Furthermore, after IVM, GV-vitrified oocytes had better spindle and F-actin integrity than oocytes vitrified at the MII stage (MII-vitrified oocytes). In accordance with this result, GV-vitrified oocytes had better ability to extrude the second polar body and support male pronucleus formation after in vitro fertilization (IVF), in comparison to MII-vitrified oocytes. Fertilization rates did not differ among groups. Finally, the ability of GV-vitrified oocytes to develop into embryos was superior to that of MII-vitrified oocytes. However, both vitrified groups showed reduced blastocyst development compared with the control group. In conclusion vitrification of porcine oocytes at the GV stage is advantageous in conferring better cytoskeletal organization and competence to develop to the blastocyst stage in comparison with vitrification at the MII stage.     

Bovine oocyte vitrification: effect of ethylene glycol concentrations and meiotic stages

Success in oocyte cryopreservation is limited and several factors as cryoprotectant type or concentration and stage of oocyte meiotic maturation are involved. The aim of the present study was to evaluate the effect of maturation stage and ethylene glycol (EG) concentration on survival of bovine oocytes after vitrification. In experiment 1, kinetics of oocyte in vitro maturation (IVM) was evaluated. Germinal vesicle (GV), germinal vesicle breakdown (GVBD), metaphase I (MI), and metaphase II (MII) oocytes were found predominantly at 0, 0–10, 10–14, and 18–24 h of IVM, respectively. In experiment 2, in vitro embryo development after in vitro fertilization (IVF) of oocytes exposed to equilibrium (ES) and vitrification solution VS-1 (EG 30%), or VS-2 (EG 40%) at 0, 12 or 18 h of IVM was evaluated. Only blastocyst rate from oocytes vitrified in SV-2 after 18 h of IVM was different from control oocytes. Hatched blastocyst rates from oocytes vitrified in VS-1 after 12 and 18 h, and SV-2 after 18 h of IVM were different from unvitrified oocytes. In experiment 3, embryo development was examined after IVF of oocytes vitrified using VS-1 or VS-2 at 0, 12 or 18 h of IVM. Rates of blastocyst development after vitrification of oocytes in VS-1 at each time interval were similar. However, after vitrification in VS-2, blastocyst rates were less at 18 h than 0 h. Both cleavage rates and blastocyst rates were significantly less in all vitrification groups when compared to control group and only control oocytes hatched. In conclusion, both EG concentration and stage of meiotic maturation affect the developmental potential of oocytes after vitrification.     

Effects of EGTA and slow freezing of bovine oocytes on post‐thaw development in vitro

Experiments were conducted to assess the morphological viability and in vitro developmental potential of bovine oocytes after exposure to Ethylene Glycol‐bis(‐aminoethyl Ether) N,N,N,N‐Tetra‐acetic Acid (EGTA) prior to slow freezing. Different concentrations of EGTA (0, 1, 5 and 10 mM) and exposure intervals (5, 10 and 15 min) were tested on immature (GV) and in vitro matured (IVM) oocytes equilibrated in 1.5 mM propylene glycol (PG) without (experiment 1) or with slow freezing (experiment 2). In addition, PG and ethylene glycol (EG) were compared for cryoprotective efficacy. In vitro maturation (IVM), in vitro fertilization (IVF) and embryo culture (IVC) were performed in defined conditions. Pretreatment of both types of oocytes with 1 mM EGTA for 5 min without freezing yielded morphological and functional results comparable to those obtained for controls while results from higher concentrations of EGTA were lower (P < 0.05). Higher rates of freeze‐thaw survival and embryonic development were obtained after pretreating GV oocytes with 1 or 5 mM EGTA for 5 min. Similarly, better results were obtained when IVM oocytes were pretreated with 1 mM EGTA for either 5 or 10 min. When pretreated with 1 mM EGTA for 5 min and frozen with PG IVM oocytes exhibited higher survival rates (P < 0.05) than those frozen with EG. However, no significant differences were observed in the in vitro development of surviving GV or IVM oocytes frozen with either PG or EG. Results suggest that a prefreeze treatment with 1 mM EGTA for 5 min can enhance oocyte viability. Conditions described enabled blastocyst development of 2.9% of GV oocytes and 8.0% of IVM oocytes after cryopreservation and IVF. Mol. Reprod. Dev. 52:86–98, 1999. © 1999 Wiley‐Liss, Inc.     

In vitro viability and ultrastructural changes in bovine oocytes treated with a vitrification solution

Abattoir-derived oocytes were exposed to a concentrated cryoprotectant solution (DAP213: 2 M DMSO, 1 M acetamide, 3 M propanediol, and 10% FCS in TCM199) for 1.5 or 5 min at the germinal vesicle (GV) stage or after maturation in vitro (IVM). Their viability was assessed by in vitro fertilization (IVF) and culture (IVC) to blastocysts. To investigate the effect of DAP213 on the ultrastructure, GV and IVM oocytes were processed for transmission electron microscopy (TEM) before (control) or after exposure to the cryoprotectant. DAP213 induced profound ultrastructural modifications to the microvilli and mitochondria, resulted in large vesicle formation, and, most significantly, caused the premature release of the cortical granules (CG). In IVM oocytes exposed to the cryoproteclant for 5 min, exocytosis of CG into the perivitelline space was common and the IVF rate was reduced (P <.05). After exposure for 5 min, GV oocytes displayed clusters of CG comparable to controls, but after IVM-IVF, polyspermy rate was increased (P <.05). Furthermore, treated GV oocytes showed a reduced rate of cleavage and blastocyst formation and an increased percentage of oocytes exhibiting alterations in organelles, whereas the viability and ultrastructure of IVM oocytes treated for 1.5 min was not different from controls. These observations demonstrate that (1) cortical granule kinetics is one of the key elements controlling fertilizability of bovine oocytes treated with cryoprotectant, and (2) GV oocytes are more sensitive to the cryoprotectant than those that have already been matured in vitro.     

Influence of cysteamine supplementation and culture in portable dry-incubator on the in vitro maturation, fertilization and subsequent development of mouse oocytes

The need to transport oocytes and embryos between two laboratories have prompted us to evaluate the effects of in vitro maturation of immature mouse oocytes in a CO2-deficient dry heat portable incubator and subsequent in vitro development of these fertilized mouse oocytes in a standard CO2 incubator. In addition, the effects of cysteamine supplementation on maturation rate and embryonic development during in vitro maturation (IVM) and culture of embryos in the portable incubator were also investigated. Germinal vesicle stage mouse oocytes, recovered at 40-h post-FSH from 6- to 8-week-old C57BL/6xCBA F1 healthy female mice, were matured in vitro in a modified TCM-199 supplemented with or without 100 microM cysteamine in a standard incubator (5% CO2; 37 degrees C) or cultured in a CO2-deficient dry heat portable incubator for 5 h at 37 degrees C and thereafter transferred to a standard incubator for further culture. The addition of cysteamine in the IVM medium significantly improved maturation rates of the GV mouse oocytes to metaphase II stage. However, cysteamine supplementation in the culture medium did not significantly improve fertilization and blastocyst formation rates of IVM and ovulated oocytes, and in vivo-derived zygotes. Culture conditions in a CO2-deficient dry heat portable incubator did not adversely affect the developmental competence of in vivo-derived zygotes and in vitro matured mouse oocytes after IVF or parthenogenetic activation. Cysteamine supplement in the IVM medium could enhance nuclear maturation of these immature oocytes during shipment.     

In vitro maturation,fertilization and development of domestic cat oocytes recovered from ovaries collected at three stages of the reproductive cycle

This study was conducted to examine the effect of the donor cat's reproductive cycle stage on in vitro maturation (IVM), in vitro fertilization (IVF), and in vitro development of oocytes recovered from ovaries that were collected and stored at 35 degrees C for a short period (1-6 h). Based on the presence or absence of follicles and corpora lutea, the ovarian pairs collected were classified into inactive, follicular, or luteal stages. Nuclear status of 161 cumulus-oocyte complexes (COCs) were examined immediately after recovery; 91.3% of the oocytes were found to be at the immature germinal vesicle (GV) stage, and 3.7% of the oocytes were at metaphase II (MII) stage. The percentage of the oocytes at the GV stage was significantly lower in the follicular stage than in the inactive stage (P < 0.01). Of the oocytes from the follicular stage, 9.1% were at MII stage. After culture for 24 h, however, the proportions of oocytes that reached metaphase I and MII were not different among the reproductive cycle stages of the ovaries collected (P > 0.05). After co-incubation with sperm, 63.1% of oocytes were fertilized, but there were no significant differences among the reproductive cycle stages of the ovaries with respect to the proportions of normal and polyspermic fertilization. However, the number of oocytes reaching cleavage stage and development to the morula and blastocyst stages from follicular stage ovaries were significantly lower (P < 0.05) than those obtained from inactive and luteal stage ovaries. These results indicate that the reproductive cycle stage of donor cat ovaries, stored at 35 degrees C, has no apparent effects on the frequencies of maturation and fertilization of oocytes, but influences developmental competence of the oocytes following IVM or IVF.     

In vitro maturation and fertilization of porcine oocytes after a 48 h culture in roscovitine, an inhibitor of p34cdc2/cyclin B kinase

Maintaining oocytes at the germinal vesicle (GV) stage in vitro may permit enhanced acquisition of the developmental competence. The objective of the current study was to evaluate the nuclear and cytoplasmic maturation in vitro of porcine oocytes after pretreatment with S-roscovitine (ROS). Cumulus oocyte complexes (COC) were treated with 50 microM ROS for 48 h and then matured for various lengths of time in a conventional step-wise in vitro maturation (IVM) system by using dibutyryl cyclic AMP. The COC that were matured in the same system for 44 h without pretreatment with ROS were used as the control group. At various periods after the start of IVM, oocytes were assessed for the meiotic stages and subjected to in vitro fertilization (IVF) with fresh spermatozoa. The ROS treatment inhibited GV breakdown of 94.4% oocytes, with the majority arrested at the GV-I stage (67.4%). Maximum maturation rate to the metaphase-II stage after ROS treatment was achieved by 44 h of IVM (92.1%) and no differences were observed with control oocytes (95.0%). Penetration rate was correlated to the maturation rate. The duration of IVM had no effects on polyspermy and male pronuclear (MPN) formation rates at 8 h post insemination (hpi), whereas both rates increased at 22 hpi. Direct comparison with controls assessed at 22 hpi confirmed a lesser MPN formation in ROS-treated oocytes (73.7% compared with 53.6%). Glutathione (GSH) concentrations were less in oocytes treated with ROS than in control oocytes (5 compared with 7.7 pmol/oocyte) as well as blastocyst rate (22.0% compared with 38.1%, respectively). These results demonstrate that cytoplasmic maturation in porcine oocytes pretreated with ROS for 48 h did not equal that of control oocytes in the current IVM system.     

FSH priming improves oocyte maturation,but priming with FSH or hCG has no effect on subsequent embryonic development in an in vitro maturation program

AIM: To determine whether maturation and subsequent blastocyst development of in vitro matured oocytes can be improved by in vivo follicle stimulating hormone (FSH) or human chorionic gonadotrophin (hCG) priming, using a mouse model. EXPERIMENTAL DESIGN: Five groups of oocytes were used: in vivo control, in vitro matured (IVM) control, IVM after 24 h in vivo priming with FSH, IVM after 48 h in vivo priming with FSH and IVM after 16 h in vivo priming with hCG. In vitro fertilization (IVF) was performed on all groups.Oocyte maturation, fertilization, blastocyst development rates and blastocyst cell numbers were assessed for all groups. RESULTS: Significant improvement in oocyte maturation was observed in the two FSH priming groups compared with the IVM control group (P<0.005 and P<0.001, respectively). There were no significant differences in fertilization between all five groups. Blastocyst development was significantly higher in the in vivo control compared to the IVM groups (P<0.001). No significant differences were observed in blastocyst cell numbers among all five groups. CONCLUSIONS: While FSH priming improves the maturation rate of IVM oocytes, FSH or hCG priming does not improve development to the blastocyst stage.     

Improved in vitro embryo development using in vivo matured oocytes from heifers superovulated with a controlled preovulatory LH surge

In bovine in vitro embryo production, the IVM step is rather successful with 80% of the oocytes reaching the MII stage. However, the extent to which the process limits the yield of viable embryos is still largely unknown. Therefore, we compared embryonic developmental capacity during IVC of IVF oocytes which had been matured in vitro with those matured in vivo. In vitro maturation was carried out for 22 h using oocytes (n = 417) obtained from 2- to 8-mm follicles of ovaries collected from a slaughterhouse in M199 with 10% fetal calf serum (FCS), 0.01 IU/mL LH, and 0.01 IU/mL FSH. In vivo matured oocytes (n = 219) were aspirated from preovulatory follicles in eCG/PG/anti-eCG-superovulated heifers 22 h after a fixed time GnRH-induced LH surge; endogenous release of the LH surge was suppressed by a Norgestomet ear implant. This system allowed for the synchronization of the in vitro and in vivo maturation processes and thus for simultaneous IVF of both groups of oocytes. The in vitro developmental potential of in vivo matured oocytes was twice as high (P < 0.01) as that of in vitro matured oocytes, with blastocyst formation and hatching rates 11 d after IVC of 49.3 +/- 6.1 (SEM; n = 10 heifers) vs 26.4 +/- 1.0% (n = 2 replicates), and 39.1 +/- 5.1% vs 20.6 +/- 1.4%, respectively. It is concluded that IVM is a major factor limiting in the in vitro production of viable embryos, although factors such as the lack of normal preovulatory development of IVM oocytes contributed to the observed differences.